Medical Marijuana Product Advancements Propelling Cannabis Industry
As Revenues From Sales Forecasted For Exponential Growth
Coral Springs, FL -- July 20, 2016 -- InvestorsHub
NewsWire -- The medical marijuana sector shows no signs of slower
growth as more states & Global governments push towards
legalization while revenue opportunities continue to steadily
rise. Experts are forecasting medical marijuana revenues to
significantly top $20 Billion by the year 2020.
New Colombia Resources, Inc. (OTC:
NEWC), a Colombian company listed in the U.S., is pleased that
Sannabis SAS, their Medical Marijuana joint venture, continues to
make headlines. Sannabis products were showcased at an
inaugural event for Caucannabis, Colombias first medical marijuana
co-operative that includes 52 Indigenous families that will legally
grow medical marijuana. Caucannabis was formed by mayors of
the Department of Cauca, home to Sannabis and Colombias largest
marijuana growing region, where 50% of the nations marijuana is
grown. The inauguration made major headlines due the visit
from Colombias Ministers of Justice and Health who support this
co-operative. To see all the press Sannabis is getting, visit the
News page of their new and improved website,http://www.sannabis.co/#!blog/csjb/
Read the full New Colombia Resources (NEWC)
Press Release at: http://financialnewsmedia.com/profiles/newc.html
Sannabis has been growing medical marijuana and producing high
quality, organic products in Cauca since 2014. In April they
hosted the mayors of the Cauca Department at their facilities to be
used as a model for the co-op. Sannabis is increasing their
production to satisfy the demand for medical marijuana medicines,
the addition of the co-op will add to the Sannabis supply chain.
The Sannabis portfolio of medical products has a first to market
advantage which is causing huge international demand and Sannabis
is fielding interest for their products from all over the
World. We expect to be the first ones with significant
products to export that are Made in Colombia, we have experts in
marijuana cultivation from Colorado and Washington on their way to
Cauca by the end of the month to teach the indigenous community
U.S. techniques and vice versa, stated John Campo, President of New
Colombia Resources, Inc. Mr. Campo was recently interviewed
by Stock Traders Talk Radio; an archived recorded version can be
found on the homepage of Stock Traders Talk atwww.stocktraderstalk.com.
In other cannabis/marijuana news and developments:
Worldwide the number of people living with diabetes has reached 422
million, and if the current trend continues, over 700 million
people are expected to be living with diabetes by 2025. Diabetes
has clearly become a healthcare crisis on a global scale,
and PharmaCyte Biotech (OTC: PMCB) (OTCQB: PMCB) recently
received some good news in the form of patent protection that will
help the company do its part in bringing a treatment to tens of
millions of these patients. PharmaCyte recently learned from
the U.S. Patent and Trademark Office (USTPO) that it now has 20
years of patent protection in the United States for the "Melligen"
cells that are a part of the company's therapy for Type 1 and
insulin-dependent Type 2 diabetes. The timing is perfect because
the same research that laid out the dramatic rise in the numbers of
people affected by diabetes, also found that the global cost of
diabetes has ballooned to $825-billion per year.
Oxis International Inc. (OTC:
OXIS) (OTCQB:
OXIS) announced that the company's innovative cancer therapies
will be profiled on Fox Business Network onSunday, July 24,
at 12:30 p.m. Eastern time. Anthony J. Cataldo,
chief executive of Oxis, discussed the company's drugs for the
treatment of cancer and other unmet medical needs on the program
Worldwide Business with Kathy Ireland.
Rocky Mountain High Brands, Inc. (OTC:
RMHB) announced recently that the Company will go on tour as a
sponsor to the red-hot Oklahoma-based country influenced rockers,
Hillbilly Vegas. The three-year sponsorship agreement will include
product promotional support at concert events, photo shoots,
distribution of promotional items, music content, promotional
appearances and a vehicle wrap of the band's 42 ft. tour bus.
Medical Marijuana, Inc. (OTC:
MJNA) announced earlier this month that the Paraguay government
has issued a new import permit for the Company's flagship product
Real Scientific Hemp Oil (RSHO) for a new patient in the country.
The Company also announced its plans to further expand into Latin
America as the cannabis industry continues gaining ground in the
region and as demand for its products increase. The Paraguay
government granted the country's first-ever import permit for RSHO
in May 2016, which marked the third country in Latin America, after
Brazil and Mexico to approve Medical Marijuana, Inc.'s cannabidiol
(CBD) hemp oil for indications including epilepsy, Parkinson's
disease and chronic pain. RSHO also has 12 medical product
registrations in Puerto Rico.
FinancialNewsMedia.com is leading provider of third party
publishing & news dissemination services. If you would
like more information regarding our news coverage solutions, please
visit financialnewsmedia.com for more details. Get
an edge on the market with our Premium News Alerts that are FREE
for a limited time at financialnewsmedia.com. Follow us
on Facebook: facebook.com/financialnewsmedia and
Twitter: twitter.com/FNMgroup.
DISCLAIMER: FN Media Group LLC (FNMG) is a third party
publisher and news dissemination service provider, which
disseminates electronic information through multiple online media
channels. FNMG is NOT affiliated in any manner with any
company mentioned herein. FNMG and its affiliated companies
are a news dissemination solutions provider and are NOT a
registered broker/dealer/analyst/adviser, holds no investment
licenses and may NOT sell, offer to sell or offer to buy any
security. FNMG's market updates, news alerts and corporate
profiles are NOT a solicitation or recommendation to buy, sell or
hold securities. The material in this release is intended to
be strictly informational and is NEVER to be construed or
interpreted as research material. All readers are strongly
urged to perform research and due diligence on their own and
consult a licensed financial professional before considering any
level of investing in stocks. All material included herein is
republished content and details which were previously disseminated
by the companies mentioned in this release. FNMG is not
liable for any investment decisions by its readers or
subscribers. Investors are cautioned that they may lose all
or a portion of their investment when investing in stocks.
For current services performed FNMG has been compensated one
thousand nine hundred dollars for news coverage of the current
press release issued by New Colombia Resources by the
Company, FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS
RELEASE.
This release contains "forward-looking statements" within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E the Securities Exchange Act of 1934, as amended and
such forward-looking statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. "Forward-looking statements" describe future expectations,
plans, results, or strategies and are generally preceded by words
such as "may", "future", "plan" or "planned", "will" or "should",
"expected," "anticipates", "draft", "eventually" or "projected".
You are cautioned that such statements are subject to a multitude
of risks and uncertainties that could cause future circumstances,
events, or results to differ materially from those projected in the
forward-looking statements, including the risks that actual results
may differ materially from those projected in the forward-looking
statements as a result of various factors, and other risks
identified in a company's annual report on Form 10-K or 10-KSB and
other filings made by such company with the Securities and Exchange
Commission. You should consider these factors in evaluating the
forward-looking statements included herein, and not place undue
reliance on such statements. The forward-looking statements in this
release are made as of the date hereof and FNMG undertakes no
obligation to update such statements.
Contact Information:
Company: FN Media Group, LLC
Contact email: editor@financialnewsmedia.com